RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Charcot-Marie-Tooth Disease: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Patient-Reported Complications and Outcomes of General, Central Neuraxial, and Peripheral Regional Anesthesia in Charcot-Marie-Tooth Disease.
Bertini Alessandro et al., Neurology. Genetics (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42668861/
- 2.
PXT3003: Lessons for therapeutic development in Charcot-Marie-Tooth disease type 1A and related neuropathies
Joshua Burns, iScience (22 September 2026)
https://doi.org/10.1016/j.isci.2026.117568
- 3.
Orthotic optimization in early Charcot-Marie-Tooth disease: A clinical case
Heleen Adams et al., Gait & Posture (18 September 2026)
https://doi.org/10.1016/j.gaitpost.2026.110298
- 4.
Impact of foot orthoses’ design on gait in children with Charcot-Marie-Tooth
Mélissa Martel et al., Gait & Posture (18 September 2026)
https://doi.org/10.1016/j.gaitpost.2026.110450
- 5.
Surgical correction of foot deformities in Charcot-Marie-Tooth-disease: Effects on personal goals and gait capacity
Heleen van der Wielen et al., Gait & Posture (18 September 2026)
https://doi.org/10.1016/j.gaitpost.2026.110554
Clinical Trials : Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
Confirmatory Study of Govorestat in CMT-SORD
NCT07191912 · Not yet recruiting · Phase 3 · Applied Therapeutics, Inc.
https://clinicaltrials.gov/study/NCT07191912
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Charcot-Marie-Tooth Disease
Charcot-Marie-Tooth disease is a group of inherited conditions that damage the peripheral nerves, causing progressive muscle weakness and reduced sensation, particularly in the feet, legs, and hands. It is the most common inherited peripheral neuropathy, affecting approximately 1 in 2,500 people worldwide. There is currently no cure, but research into gene therapies and other treatments is advancing rapidly.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
BACKGROUND AND OBJECTIVES: Anesthetic management for Charcot-Marie-Tooth disease (CMT) is still controversial and source of concerns for both anesthetists and patients. We explored the frequency of self-reported complications following anesthesia in a large cohort of patients with CMT compared with unaffected controls. METHODS: We administered an online ad hoc questionnaire to patients enrolled in the Italian CMT Registry and to unaffected controls. The questionnaire collected self-reported adverse events following any anesthetic procedure undergone during the participants' lifetime. Anesthetic procedures were categorized as general anesthesia (including endotracheal intubation or deep sedation), central neuraxial anesthesia (epidural or spinal anesthesia), and peripheral regional anesthesia (plexus or peripheral nerve blocks). RESULTS: Overall, the questionnaire was completed by 290 patients with CMT (160 female patients; mean age 47.8 ± 13.1 years) and 94 controls (46 female patients; mean age 47.5 ± 13.2 years), and a total of 508 and 161 procedures, respectively, were analyzed. The rate of self-reported complications following general, central neuraxial, and peripheral regional anesthesia did not differ between patients with CMT and controls. All reported events in the CMT cohort were transient and fully resolved, with a favorable anesthetic outcome in all cases. Demyelinating CMT subtypes were not more likely to report complications than axonal subtypes. Moreover, experienced complications following anesthesia for cesarean delivery occurred with similar frequency in patients with CMT and controls. DISCUSSION: Anesthesia-related complications are not reported more frequently in patients with CMT compared with controls. However, longitudinal studies incorporating objective clinical assessments and detailed information on anesthetic agents are warranted.
Common Questions
What is Charcot-Marie-Tooth Disease?
Charcot-Marie-Tooth disease is a group of inherited conditions that damage the peripheral nerves, causing progressive muscle weakness and reduced sensation, particularly in the feet, legs, and hands. It is the most common inherited peripheral neuropathy, affecting approximately 1 in 2,500 people worldwide. There is currently no cure, but research into gene therapies and other treatments is advancing rapidly.
How many clinical trials are available for Charcot-Marie-Tooth Disease?
RareWays currently indexes 47 clinical trials for Charcot-Marie-Tooth Disease, of which 16 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Charcot-Marie-Tooth Disease come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Charcot-Marie-Tooth Disease.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.